Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/24244
Title: A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antibiotics, Antineoplastic/*administration & dosage/adverse effects,Breast Neoplasms/*drug therapy,Disease-Free Survival,Drug Administration Schedule,Epirubicin/*administration & dosage/adverse effects,Female,Humans,Middle Aged,Survival Analysis,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/24244
ISSN: 0923-7534
Link: http://www.ncbi.nlm.nih.gov/pubmed/9496386
http://annonc.oxfordjournals.org/content/8/12/1213.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Fountzilas-1997-A randomized study o.pdf1.71 MBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons